Cytokines in heart diseases;Zytokine bei herzerkrankungen

Internist

Volumn 42, Issue 1, 2001, Pages 75-84

  Rauchhaus, M ^a   Muller Werdan U ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

CARDIOMYOPATHY; CARDIOVASCULAR RISK; HEART DISEASE; HEART FAILURE; INFLAMMATION; PATHOGENESIS; PROGNOSIS; REVIEW;

CARDIOMYOPATHIES; CYTOKINES; HEART DISEASES; HEART FAILURE, CONGESTIVE; HUMANS; MYOCARDIUM; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035104302     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001080050726     Document Type: Review

References (67)

1. Atherosclerosis - An inflammatory disease
2. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease
3. The relationship of the erythrocyte sedimentation rate to inflammatory cytokines and survival in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors
4. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the Studies of Left Ventricular Dysfunctions (SOLVD)
5. Tumor necrosis factor-alpha and tumor necrosis factors in the failing human heart
6. Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction
7. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men
8. Elevated levels of interleukin-6 in unstable angina
9. Cytokines in myocarditis and cardiomyopathies
10. Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin
11. The recent decline in mortality from coronary heart disease, 1980-1990. The effect of secular trends in risk factors and treatment
12. Heart failure: A medical hydra
13. History, definition, and classification of heart failure
14. The neurohormonal hypothesis: A theory to explain the mechanism of disease progression in heart failure
15. The "muscle hypothesis" of chronic heart failure
16. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial
17. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure
18. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure
19. Basic mechanisms in heart failure: The cytokine hypothesis
20. Endotoxin and immune activation in chronic heart failure: A prospective cohort study
21. Increased levels of serum neopterin and decreased production of neutrophil superoxide anions in chronic heart failure with elevated levels of tumor necrosis factor-alpha
22. Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important progrnostic predictor in patients with congestive heart failure
23. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure
24. Elevated soluble CD14 receptors and altered cytokines in chronic heart failure
25. Plasma cytokine parameters and mortality in patients with chronic heart failure
26. Endotoxin in chronic heart failure
27. The endotoxin-lipoprotein hypothesis
28. Preoperative and postoperative endotoxemia in children with congenital heart disease
29. Association of endotoxemia with carotid atherosclerosis and cardiovascular disease: Prospective results from the Bruneck Study
30. Tumour necrosis factor is expressed in cardiac tissues of patients with heart failure
31. Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart
32. Tumour necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy
33. Hemodynamic regulation of tumor necrosis factor-alpha gene and protein expression in adult feline myocardium
34. Decreased expression of tumor necrosis factor-alpha in failing human myocardium after mechanical circulatory support : A potential mechanism for cardiac recovery
35. Circulating concentrations of proinflammatory cytokines in mild or moderate heart failure secondary to ischemic or idiopathic dilated cardiomyopathy
36. Increased oxidative stress in patients with congestive heart failure
37. Relation between serum uric acid and lower limb blood flow in patients with chronic heart failure
38. Nuclear factor-kappaB: A pivotal transcription factor in chronic inflammatory diseases
39. Oscillatory breathing patterns during wakefulness in patients with chronic heart failure: Clinical implications and role of augmented peripheral chemosensitivity
40. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin
41. Immune modulation by catecholamines-a potential mechanism of cytokine release in heart failure?
42. Noradrenaline stimulates cardiomyocytes to produce interleukin-6, indicative of a proinflammatory action, which is suppressed by carvedilol
43. Circulating interleukin-6 in severe heart failure
44. Cardiodepression by tumor necrosis factor-alpha
45. Sphingosine mediates the immediate negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian cardiac myocyte
46. TNF-alpha and IL-1 alpha inhibit both pyruvate dehydrogenase activity and mitochondrial function in cardiomyocytes: Evidence for primary impairment of mitochondrial function
47. Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart
48. Tumor necrosis factor alpha decreases inositol phosphate formation and phosphatidylinositol-bisphosphate (PIP2) synthesis in rat cardiomyocytes
49. Tumor necrosis factor alpha (TNF alpha) is cardiodepressant in pathophysiologically relevant concentrations without inducing inducible nitric oxide-(NO)-synthase (iNOS) or triggering serious cytotoxicity
50. Endotoxin and tumor necrosis factor alpha exert a similar proinflammatory effect in neonatal rat cardiomyocytes, but have different cardiodepressant profiles
51. Cellular basis for the acute inhibitory effects of IL-6 and TNF-alpha on excitation-contraction coupling
52. Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphin-golipid signaling cascade in cardiac cell death
53. Tumor necrosis factor-alpha provokes a hypertrophic growth response in adult cardiac myocytes
54. Endogenous tumor necrosis factor protects the adult cardiac myocyte against ischemic-induced apoptosis in a murine model of acute myocardial infarction
55. Catabolism in chronic heart failure
56. The role of TNF-alpha and TNF receptors in obesity and insulin resistance
57. Early prediction of outcome in score-identified, postcardiac surgical patients at high risk for sepsis, using soluble tumor necrosis factor receptor-p55 concentrations
58. Septic cardiomyopathy
59. Evaluation of definitions and parameters for sepsis assessment in patients after cardiac surgery
60. Expression, activity and functional significance of inducible nitric oxide synthase in the failing human heart
61. Beta-adrenergic blockade in developing heart failure: Effects on myocardial inflammatory cytokines, nitric oxide, and remodeling
62. Effect of high- versus low-dose angiotensin converting enzyme inhibition on cytokine levels in chronic heart failure
63. Safety and efficacy of a soluble P75 tumor necrosis factor receptor (Enbrel, etanercept) in patients with advanced heart failure
64. Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension
65. The activated immune system in congestive heart failure - From dropsy to the cytokine paradigm